Oral surgery in patients using oral anticoagulant drugs and warfarin
DOI:
https://doi.org/10.33448/rsd-v11i6.29061Keywords:
Tooth extraction; Anticoagulant; Bleeding; Surgery; Teaching.Abstract
Surgical procedures are in the daily life of the dental surgeon and due to the longer maintenance of natural teeth by patients in relation to age, oral surgeries are becoming increasingly common in patients who use oral anticoagulants, so the dental surgeon must stay aware of the actions to be taken. This study aims to review the literature on the conduct to be taken in oral surgeries in patients who use anticoagulants continuously, evaluating the risk of discontinuing this medication and the risk of bleeding. For the construction of this work, a bibliographic survey was carried out in the databases SciVerse Scopus, Scientific Electronic Library Online (Scielo), U.S. National Library of Medicine (PUBMED) and ScienceDirect, using the Mendeley reference manager. The results of this research reveal that the continuation of drug therapy with warfarin in patients undergoing simple and atraumatic tooth extractions can be performed as long as the patient is in the appropriate therapeutic range analyzed through the INR. Regarding the extraction of invasive third molars, the procedure can be performed when the INR is up to 2.11, and your medical history is evaluated in detail, but more studies are needed for this type of procedure.
References
Aframian, D. J., Lalla, R. V., & Peterson, D. E. (2007). Management of dental patients taking common hemostasis-altering medications. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, 103(SUPPL.), S45.e1-S45.e11. https://doi.org/10.1016/j.tripleo.2006.11.011
Andrade, M. V. S., Andrade, L. A. P., Bispo, A. F., Freitas, L. de A., Andrade, M. Q. S., Feitosa, G. S., & Feitosa-Filho, G. S. (2018). Evaluation of the bleeding intensity of patients anticoagulated with warfarin or dabigatran undergoing dental procedures. Arquivos Brasileiros de Cardiologia, 111(3), 394–399. https://doi.org/10.5935/abc.20180137
Bajkin, B. V, Vujkov, S. B., Milekic, B. R., & Vuckovic, B. A. (2015). Risk factors for bleeding after oral surgery in patients who continued using oral anticoagulant therapy. The Journal of the American Dental Association, 146(6), 375–381. https://doi.org/https://doi.org/10.1016/j.adaj.2015.01.017
Breik, O., Cheng, A., Sambrook, P., & Goss, A. (2014). Protocol in managing oral surgical patients taking dabigatran. Australian Dental Journal, 59(3), 296–301; quiz 401. https://doi.org/10.1111/adj.12199
Breik, O., & Grubor, D. (2008). The incidence of mandibular third molar impactions in different skeletal face types. Australian Dental Journal, 53(4), 320–324. https://doi.org/10.1111/j.1834-7819.2008.00073.x
Büller, H. R., Agnelli, G., Hull, R. D., Hyers, T. M., Prins, M. H., & Raskob, G. E. (2004). Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126(3 Suppl), 401S-428S. https://doi.org/10.1378/chest.126.3_suppl.401S
Cannon, P. D., & Dharmar, V. T. (2003). Minor oral surgical procedures in patients on oral anticoagulants--a controlled study. Australian Dental Journal, 48(2), 115–118. https://doi.org/10.1111/j.1834-7819.2003.tb00019.x
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., Wang, S., Alings, M., Xavier, D., Zhu, J., Diaz, R., Lewis, B. S., Darius, H., Diener, H.-C., Joyner, C. D., & Wallentin, L. (2009). Dabigatran versus warfarin in patients with atrial fibrillation. The New England Journal of Medicine, 361(12), 1139–1151. https://doi.org/10.1056/NEJMoa0905561
Feliciano, A. G. R. de S. (2018). Abordagem cirurgica odontológica em pacientes que fazem uso de anticoagulantes. 1–10.
Guyatt, G. H., Akl, E. A., Crowther, M., Gutterman, D. D., & Schuünemann, H. J. (2012). Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141(2, Supplement), 7S-47S. https://doi.org/https://doi.org/10.1378/chest.1412S3
Keeling, D. M., Baglin, T., Tait, C., Watson, H., Perry, D., Baglin, C., Kitchen, S., & Makris, M. (2011). Guidelines on oral anticoagulation with warfarin - fourth edition. British Journal of Haematology, 154(3), 311–324. https://doi.org/10.1111/j.1365-2141.2011.08753.x
Lamminen, H., Niiranen, S., Niemi, K., Mattila, H., & Kalli, S. (2002). Personal health care and the new media in anticoagulant treatment. Scandinavian Journal of Primary Health Care, 20(2), 123–125.
Lu, S.-Y., Lin, L.-H., & Hsue, S.-S. (2018). Management of dental extractions in patients on warfarin and antiplatelet therapy. Journal of the Formosan Medical Association = Taiwan Yi Zhi, 117(11), 979–986. https://doi.org/10.1016/j.jfma.2018.08.019
Müller, M., Schlittler, F., Schaller, B., Nagler, M., Exadaktylos, A. K., & Sauter, T. C. (2019). Characteristics, treatment and outcome of bleeding after tooth extraction in patients on DOAC and phenprocoumon compared to non-anticoagulated patients—a retrospective study of emergency department consultations. Clinical Oral Investigations, 23(5), 2273–2278. https://doi.org/10.1007/s00784-018-2676-7
Pereira, A., Shitsuka, D., Parreira, F., & Shitsuka, R. (2018). Método Qualitativo, Quantitativo ou Quali-Quanti. In Metodologia da Pesquisa Científica. https://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_Metodologia-Pesquisa-Cientifica.pdf?sequence=1. Acesso em: 28 março 2020.
Petursson, H., Getz, L., Sigurdsson, J. A., & Hetlevik, I. (2009). Current European guidelines for management of arterial hypertension: are they adequate for use in primary care? Modelling study based on the Norwegian HUNT 2 population. BMC Family Practice, 10, 70. https://doi.org/10.1186/1471-2296-10-70
Rosencher, N., Arnaout, L., Chabbouh, T., & Bellamy, L. (2008). [Rivaroxaban (Xarelto): efficacy and safety]. Annales francaises d’anesthesie et de reanimation, 27 Suppl 3, S22-7. https://doi.org/10.1016/S0750-7658(08)75143-8
Shamoun, F. E., Martin, E. N., & Money, S. R. (2013). The novel anticoagulants: The surgeons’ prospective. Surgery (United States), 153(3), 303–307. https://doi.org/10.1016/j.surg.2012.09.016
Teles, J. S., Fukuda, E. Y., & Feder, D. (2012). Varfarina : perfil farmacológico e interações medicamentosas com antidepressivos Warfarin : pharmacological profile and drug interactions with antidepressants. Einstein, 10(1), 110–115.
Virjo, I., Mäkelä, K., Aho, J., Kalliola, P., Kurunmäki, H., Uusitalo, L., Valli, M., & Ylinen, S. (2010). Who receives anticoagulant treatment with warfarin and why? A population-based study in Finland. Scandinavian Journal of Primary Health Care, 28(4), 237–241. https://doi.org/10.3109/02813432.2010.514138
Wallvik, J., Själander, A., Johansson, L., Bjuhr, O., & Jansson, J.-H. (2007). Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics. Scandinavian Journal of Primary Health Care, 25(2), 123–128. https://doi.org/10.1080/02813430601183108
Weitz, J. I., Hirsh, J., & Samama, M. M. (2008). New antithrombotic drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 133(6 Suppl), 234S-256S. https://doi.org/10.1378/chest.08-0673
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Rayza Brito Silva; Lucas Dantas Pereira; Marcelo Costa Rodrigues ; Grace Kelly Martins Carneiro ; Ilana Francisca de Sousa Araújo Albuquerque; Mateus de Lima Santos; Deusa Vitória Alves Raposo; Anna Clara Costa Gomes; Marianny Vasconcelos Alves; Richard Mendes Lins
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.